Review
doi: 10.1007/s10198-005-0284-3.
Economic evidence in anxiety disorders: a review
Affiliations
- PMID: 15754067
- DOI: 10.1007/s10198-005-0284-3
Item in Clipboard
Review
Economic evidence in anxiety disorders: a review
Eur J Health Econ.
2004 Oct.
No abstract available
Similar articles
-
Human and economic burden of generalized anxiety disorder.Depress Anxiety. 2008;25(1):72-90. doi: 10.1002/da.20257. Depress Anxiety. 2008. PMID: 17146763 Review.
-
The high cost of anxiety.Bus Health. 1997 Aug;15(8):51-2. Bus Health. 1997. PMID: 10170212 No abstract available.
-
Economic evidence in affective disorders: a review.Eur J Health Econ. 2004 Oct;5 Suppl 1:S12-20. doi: 10.1007/s10198-005-0283-4. Eur J Health Econ. 2004. PMID: 15754066 Review. No abstract available.
-
Economic evidence in addiction: a review.Eur J Health Econ. 2004 Oct;5 Suppl 1:S5-12. doi: 10.1007/s10198-005-0282-5. Eur J Health Econ. 2004. PMID: 15754074 Review. No abstract available.
-
Economic evidence in migraine and other headaches: a review.Eur J Health Econ. 2004 Oct;5 Suppl 1:S43-54. doi: 10.1007/s10198-005-0288-z. Eur J Health Econ. 2004. PMID: 15754073 Review. No abstract available.
Cited by
-
[Cost of disorders of the brain in Austria in the year 2004].Wien Klin Wochenschr. 2007;119(3-4):91-8. doi: 10.1007/s00508-006-0725-8. Wien Klin Wochenschr. 2007. PMID: 17347857 German.
-
Cost of disorders of the brain in Italy.Neurol Sci. 2008 Apr;29(2):99-107. doi: 10.1007/s10072-008-0868-7. Epub 2008 May 16. Neurol Sci. 2008. PMID: 18483707
-
Current considerations in the treatment of generalized anxiety disorder.CNS Drugs. 2009;23(2):103-20. doi: 10.2165/00023210-200923020-00002. CNS Drugs. 2009. PMID: 19173371 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
